Concepedia

Publication | Open Access

Lenalidomide improves the antitumor activity of CAR-T cells directed toward the intracellular Wilms Tumor 1 antigen

16

Citations

19

References

2021

Year

Abstract

These results demonstrate that lenalidomide potentiates WT1 CAR-T activity and paves the way to evaluate the combination of LEN with CAR-T for a planned clinical trial.

References

YearCitations

Page 1